Ruud van Winkel, MD, PhD

Original Research

Prediabetes in Patients Treated With Antipsychotic Drugs

December 27, 2011

Article

Are Weight Gain and Metabolic Side Effects of Atypical Antipsychotics Dose Dependent? A Literature Review

July 21, 2009

Article

The Impact of Mentorship

August 31, 2008

Article

Psychiatric Diagnosis as an Independent Risk Factor for Metabolic Disturbances: Results From a Comprehensive, Naturalistic Screening Program

August 31, 2008

Article

Major Changes in Glucose Metabolism, Including New-Onset Diabetes, Within 3 Months After Initiation of or Switch to Atypical Antipsychotic Medication in Patients With Schizophrenia and Schizoaffective Disorder

March 14, 2008

Letter to the Editor

Reply to Applicability of the Oral Glucose Tolerance Test in Assessing Prevalence and Incidence of Diabetes Mellitus in Schizophrenia

August 15, 2007

Original Research

Treatment With Rosuvastatin for Severe Dyslipidemia in Patients With Schizophrenia and Schizoaffective Disorder

December 15, 2006

Original Research

Screening for Diabetes and Other Metabolic Abnormalities in Patients With Schizophrenia and Schizoaffective Disorder: Evaluation of Incidence and Screening Methods.

October 16, 2006